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Abstract Background: Mild cognitive impairment (MCI) prodromic of vascular dementia is expected to have
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Methods: In a sample of cerebral small vessel disease (SVD) patients, we assessed MCI subtypes
distributions according to different operationalization of Winblad criteria and compared the neuro-
imaging features of single versus multidomain MCI. We applied three MCI diagnostic scenarios in
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more frequent in multidomain compared with single domain.
Conclusions: Operationalizing MCI criteria changes the relative frequency of MCI subtypes. Non-
amnestic single domain MCI may be a previously nonrecognized type of MCI associated with SVD.
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1. Background
Mild cognitive impairment (MCI) is an intermediate state
between normal cognitive status and dementia; it is consid-
ered a risk factor for dementia and has become a focus of
several clinical and intervention trials. MCI is generally
defined with the aid of neuropsychological tests providing
evidence for object impairment with intact global cognitive
functioning and activities of daily living. The criteria and the
operationalization of MCI have been subjected to much
debate as there is no real agreement regarding neuropsycho-
logical tests, the number and/or type of cognitive domains to
be assessed, and the proper use of neuropsychological cut
scores [1]. The lack of a universal operational definition of
MCI resulted in divergent outcomes in terms of prevalence
and progression rates across studies [2].
In 2003, a multidisciplinary and international experts
group proposed specific recommendations for MCI diag-
nostic criteria [3]. The definition of MCI according to
Winblad et al.’s criteria includes four clinical subtypes:
amnestic MCI (A-MCI, single or multiple domain) and non-
amnestic MCI (NA-MCI, single or multiple domain). It has
been hypothesized that different MCI subtypes subtend
different etiologies [4,5]; amnestic MCI, either single or
multiple domain, was considered to have a degenerative
etiology, whereas multiple domain MCI, either amnestic or
not, a vascular etiology.
Subcortical ischemic vascular disease caused by small
vessel disease (SVD) has been shown to be closely associ-
ated with cognitive impairment [6,7], particularly with
deficits in attention and executive function, and slowing of
motor performance and information processing [8–10].
The clinical spectrum of vascular cognitive impairment
(VCI) ranges from MCI to dementia [6] and a recent pro-
posal of diagnostic criteria for vascular MCI highlights the
need of an objective evidence of decline using validated
measures of cognitive functions and giving equal importance
to several cognitive domains [11].
We aimed to study the effects of operationalizing Winblad
et al.’s clinical consensus criteria on the MCI subtypes distri-
butions in a sample of nondemented patients with cerebral
SVD.We hypothesized that the frequency ofMCI and its sub-
types may be influenced by the operationalization of criteria.
For example, using less restrictive criteria could increase the
frequency of multidomain subtype that is, however, expected
to be prominent in a sample of patients with cerebrovascular
disease. The second aim was to compare the neuroimaging
features across different MCI subtypes.
2. Methods
The vascular MCI (VMCI)-Tuscany study is an ongoing
multicenter, prospective, observational study aimed at eval-
uating predictors of the transition from VMCI (defined by
the presence of moderate-to-severe white matter lesions) to
dementia [12]. The study methodology has been reported
elsewhere [12]. To be included, outpatients, referred from
neurologic or geriatric units, had to be classified as affected
by MCI with SVD according to the following inclusion
criteria: (1) MCI defined according to Winblad et al.’s
criteria [3] and (2) evidence on magnetic resonance imaging
(MRI) of moderate-to-severe degrees of white matter hyper-
intensities (WMH) according to the modified version of the
Fazekas scale [13]. The degree of WMH severity was rated
on fluid attenuated inversion recovery sequences taking into
account only deep and subcortical white matter lesions.
The modified Fazekas scale is a visual scale based on a
categorization into three severity classes: grade 1 (mild
WMH) 5 single lesions ,10 mm, areas of “grouped” le-
sions ,20 mm in any diameter; grade 2 (moderate
WMH) 5 single lesions between 10 and 20 mm, areas of
“grouped” lesions .20 mm in any diameter, no more than
“connecting bridges” between individual lesions; and grade
3 (severe WMH) 5 single lesions or confluent areas of hy-
perintensity !20 mm in any diameter. According to the
study protocol, each patient underwent an extensive clinical
and neuropsychological assessment and an MRI examina-
tion [12]. The study was approved by local ethics commit-
tees, and each patient gave a written informed consent.
We developed a neuropsychological test battery thought
to be specific for MCI due to SVD to allow automation
and standardization of the scoring procedures and to obtain
a cognitive profile for each patient. The development and
psychometric properties of the VMCI-Tuscany neuropsy-
chological battery were detailed in a methodological article
[14]. For the construction of the VMCI-Tuscany neuropsy-
chological battery, tests were selected among those recom-
mended for VCI [15] and having recent and robust norms
based on healthy Italian adult samples [16]. We took primar-
ily into consideration the protocols proposed by the National
Institute for Neurological Disorders and Stroke and the
Canadian Stroke Network consensus conference on harmo-
nization standards for VCI [15] and selected the tests that
had received validation, correction, and evaluation norms
based on healthy Italian adult samples. The review of Italian
neuropsychological normative studies started from the work
of Bianchi and Dai Pr!a [16], and proceeded with the analysis
of the original papers. Most of these studies applied the
equivalent scores (ES) methodology proposed by Capitani
and Laiacona [17]. ES methodology is a nonparametric
norming method based on percentiles and independent
from the distribution form. ES is an ordinal 5-point scale
(ranging from 0 to 4). The main characteristic of ES method-
ology is to fix the outer tolerance limit of the left queue of the
adjusted scores so that it is possible to assess, with a known
risk of error (,5%), the cutoff splitting the bottom 5% of the
population and representing pathologic performance
(ES 5 0). On the other end of the scale, ES 5 4 indicates
an optimal performance (!median), while the limits for
ES 5 1, 2, and 3 are established portioning the distribution
of adjusted scores between the 5th and the 50th centiles
into equal intervals. ES 5 1 indicates a borderline
E. Salvadori et al. / Alzheimer’s & Dementia- (2015) 1-122
performance (an adjusted score between the outer and inner
confidence limits for the 5th centile of the normal popula-
tion), whereas ES 5 2, 3 represent normal performances.
ES methodology allows to convert age and education-
adjusted scores into comparable ones having the same unit
of measure and to compare the performances from the
various tests so as to obtain a cognitive profile of the
impaired and preserved functions.
The VMCI-Tuscany neuropsychological battery in-
cludes two global cognitive functioning tests and other
nine tests which cover a wide range of cognitive abilities
(Table 1). ES methodology was available for all the tests
included in the battery except for the symbol digit modal-
ities test.
Trail making test (TMT, part A and B) administration had
a time limit: if patients did not complete the task in 5minutes,
the examiner stopped the administration and scored 300 sec-
onds. In this case, raw scores were not adjusted for age and
education while an ES5 0 was assigned. The administration
of TMT-B had two preliminary restrictions: the completion
of the TMT-A in ,300 seconds and the knowledge of the
correct order of the alphabet letters.
Data collected were entered into a database on a specif-
ically developed Web site (www.vmci-tuscany.it). Raw
scores were automatically adjusted for demographic vari-
ables using regression equations extracted by normative
studies and then transformed into ES.
The diagnosis of MCI according to the Winblad et al.’s
criteria [3] requires specific prerequisites: (1) patients or
caregivers complaints about cognitive deficits and (2) no
or minimal disability in activities of daily living (no impair-
ment at all on activities of daily living scale [28] and no
impairment or only one item compromised on instrumental
activities of daily living scale [29]; Fig. 1). In our operation-
alization of MCI diagnostic algorithm, prerequisites’ defini-
tion was maintained and we worked on the definition of the
objective cognitive impairment and the classification of
cognitive domains.
The Winblad et al.’s MCI diagnostic algorithm requires
the three following hierarchical steps: (1) definition of
objective cognitive impairment; (2) definition of an objec-
tive impairment in memory; and (3) definition of an objec-
tive cognitive impairment in cognitive domains other than
memory (Fig. 1). For each of the three steps, we defined:
(1) how much each score had to be below the mean to
be considered impaired and (2) how many scores were
impaired. We built three possible scenarios: (1) at least
one score borderline (ES 5 1; corresponding to our inclu-
sion criterion); (2) at least two scores borderline; and (3) at
least one score frankly impaired (ES 5 0 or an adjusted
score lower than the 5th centile of the normal population;
Fig. 1). To this purpose, we used the 12 scores deriving
from the 9 neuropsychological tests (Table 1): the immedi-
ate and delayed recalls of the Rey auditory-verbal learning
test were used as two different scores, as well as the copy
and the delayed reproduction of the Rey-Osterrieth com-
plex figure, and the part A and B of the trail making test.
As stated before, ES methodology was not available for
the symbol digit modalities test and its performance was
classified as “abnormal” when the adjusted score was
below the 5th centile of the normal population (ES 5 0)
or “normal” when the adjusted score was above the 5th
centile (no ES was assigned).
An additional issue was the definition of cognitive do-
mains. In a previous methodological article on psychometric
properties of the VMCI-Tuscany neuropsychological bat-
tery, a confirmatory factor analysis showed a good fit of
the four theoretically assumed dimensions to empirical
data [14]. Based on those findings, we considered four
cognitive domains: memory (assessed by four cognitive
scores), attention/executive functions (five cognitive scores),
language (two cognitive scores), and constructional praxis
(one cognitive score; Table 1). In scenario 2, considering
constructional praxis domain, that is assessed in our battery
by only one score, we applied the restricted criterion “at least
one score impaired.”
The MRI baseline scans were centrally revised at the
NEUROFARBADepartment, University of Florence. Visual
assessment of neuroimaging was performed by an experi-
enced neurologist (A.P.) who was blind to clinical details
and MCI classification. After the central MRI revision, of
the 200 patients enrolled in the baseline VMCI-Tuscany
cohort, 47 were excluded because of the evidence of
WMH of only mild degree (modified Fazekas scale 5 1).
The neuroimaging variables used in the present study
were: (1) WMH (modified Fazekas scale) [13], lacunar in-
farcts (total number in the entire brain) [30], global cortical
Table 1
The VMCI-Tuscany neuropsychological battery
Cognitive domain ES Test




Memory * Rey auditory-verbal learning
test (RAVL) [20] (immediate
recall)
* Rey auditory-verbal learning test
(RAVL) [20] (delayed recall)
* Short story [21]
* Rey-Osterrieth complex figure
(ROCF) (recall) [22]
Attention and executive functions * Trail making test, part A [23]
* Visual search [24]
Symbol digit modalities test
(SDMT) [25]
* Color word Stroop test [26]
* Trail making test, part B [23]
Language * Phonemic verbal fluency [27]
* Semantic verbal fluency [27]
Constructional praxis * Rey-Osterrieth complex figure
(ROCF) (copy) [22]
*Equivalent score methodology available.
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atrophy (Pasquier visual scale) [31], and medial temporal
lobe atrophy (MTA) (Scheltens scale) [32]. Forty randomly
selected scans were scored twice for the determination of the
intrarater reliability, which was good (weighted Cohen’s k:
MWH 5 0.91; lacunar infarcts 5 0.82; global cortical
atrophy 5 0.62; and MTA 5 0.86).
2.1. Statistical analysis
Correlations across neuropsychological tests (Pearson’s
r) and the Cronbach’s a coefficients were used to verify
the internal consistency of cognitive domains.
Descriptive statistics were used to show frequency distribu-
tions of MCI subtypes across the three scenarios. To show the
overlapping of distributions of MCI subtypes in all scenarios,
95% confidence intervals (CI) for percentages were calculated
by Wilson score method with a correction for continuity [33].
Descriptive statisticswere also used to showmeans and stan-
darddeviations (SD)ofminimental state examination (MMSE)
scores for each MCI subgroup, and univariate analysis of vari-
ance was applied to verify significant differences in MMSE
scores distributions acrossMCI subgroups within all scenarios.
Univariate statistical analyses (Pearson’s c2 test) were
used to compare single and multiple domain MCI groups
in terms of neuroimaging variables (WMH, lacunar in-
farcts, global cortical atrophy, and MTA) in the whole sam-
ple of patients classified as MCI according to scenario 1.
Descriptive statistics were used to verify frequency distri-
butions of neuroimaging variables in MCI subtypes in
both scenarios 1 and 3 (95% CI for percentages calculated
Fig. 1. Operationalization of theMCI diagnostic algorithm according to three possible scenarios. Abbreviations:MCI, mild cognitive impairment; ADL, Activities
of Daily Living; IADL, Instrumental Activities of Dailiy Living.
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by Wilson score method with a correction for continuity).
For statistical analysis, lacunar infarcts were coded as ab-
sent or present, mean MTA of the bilateral scores was
calculated and dichotomized (MTA score 0–2.5, MTA
score !3), and global cortical atrophy scores were dichot-
omized (global cortical atrophy score 0–2, global cortical
atrophy score 3).
3. Results
Of the 153 enrolled patients, 84 (55%) were males, and
the mean (6SD) age and years of education were
74.76 6.9 and 7.96 4.2, respectively. Mean age and educa-
tion level were not significantly different among MCI sub-
types in any of the three scenarios (data not shown).
Concerning vascular risk factors distributions, of the 153 pa-
tients, 125 (82%) had hypertension, 91 (60%) had hypercho-
lesterolemia, 22 (14%) had diabetes, 67 (44%) reported
smoking habits, 57 (37%) had history of stroke, and 46
(30%) consumed alcohol.
As shown in Table 2, across neuropsychological tests
of the same cognitive domain, all Pearson’s correlation
coefficients resulted statistically significant and Cron-
bach’s a were .0.650 showing a good internal consis-
tency of each domain. No measure of internal
consistency could be calculated for the constructional
praxis domain (assessed by only the immediate copy of
the Rey-Osterrieth complex figure). Nevertheless, this
test resulted significantly although moderately correlated
with the delayed reproduction of the Rey-Osterrieth com-
plex figure (r 5 0.217, P , .01), the TMT-A (r 5 0.201,
P , .05), and the phonemic verbal fluency (r 5 0.162,
P , .05).
Percentage distributions of subjects categorized accord-
ing to different ES values for all the 12 cognitive scores
used in the operationalization of MCI diagnostic criteria
are shown in the Online Supplemental Table. Percentages
of patients with at least a borderline performance were
approximately 50% for all tests included in the memory
domain except the short story test that resulted sparsely
impaired. In the attention/executive domain, percentages
of patients with at least a borderline performance were be-
tween 40% and 60% in all tests. The Rey-Osterrieth complex
figure resulted the most difficult test for the patients (66%
with abnormal performances and 3% with borderline perfor-
mances), whereas language tests resulted normal in approx-
imately two-third of our sample.
The application of the three scenarios led to the following
distributions of MCI subtypes (Fig. 2).
3.1. Scenario 1 (at least one score borderline)
This was the inclusion MCI criteria in our study, and
consequently all the 153 enrolled patients were classified
as MCI. The A-MCI type prevailed (78%; 95% CI, 70–84)
and 86% of patients resulted to be of the multiple domain
type (72% A-MCI; 95% CI, 64–79; 14% NA-MCI; 95%
CI, 9–21).
3.2. Scenario 2 (at least two scores borderline)
Applying this intermediate criterion, of the 153 enrolled
patients, 3 (2%) resulted cognitively normal. For further
four MCI patients, we were not able to define the MCI sub-
type because they had two scores borderline but only one in
the memory domain. All these seven patients fell into the
A-MCI group (three single domain and four multiple
domain) in scenario 1.
Passing from scenario 1 to scenario 2, of the 153 MCI pa-
tients, 119 were classified in the same subtypes, 20 moved
from the A-MCI multiple domain group to the other sub-
types (11 NA-MCI multiple domain, 7 NA-MCI single
domain, and 2 A-MCI single domain), and 7 moved within
NA-MCI from multiple to single domain group.
3.3. Scenario 3 (at least one score impaired)
Applying this restricted criterion, of the 153 enrolled pa-
tients, 7 (5%) resulted cognitively normal, 59% (95% CI,
50–67) were A-MCI and 73% resulted to be of multiple
domain type (53% A-MCI; 95% CI, 44–61; 20%
NA-MCI; 95% CI, 14–28).
The distribution ofMCI subtypes was almost the same for
both the intermediate and restricted criterion. Passing from
scenario 2 to scenario 3, of the 146 MCI patients, 9 moved
from the A-MCI multiple domain group to other subtypes
(4 NA-MCI multiple domain, 4 NA-MCI single domain,
and 1 A-MCI single domain).
Table 2
Internal consistency of cognitive domains
Cognitive domain
Memory (Cronbach’s a 5 0.671)
RAVL (immediate) RAVL (delayed) Short story
RAVL (delayed) 0.678**
Short story 0.337** 0.352**
ROCF (recall) 0.289** 0.191* 0.225**
Cognitive domain
Attention and executive functions (Cronbach’s
a 5 0.761)
TMT-A Visual search SDMT Stroop test
Visual search 0.509**
SDMT 0.515** 0.388**
Stroop test 0.287** 0.362** 0.255**
TMT-B 0.553** 0.446** 0.513** 0.415**
Language (Cronbach’s a 5 0.651)
Semantic fluency
Phonemic fluency 0.331**
Abbreviations: RAVL, Rey auditory-verbal learning test; ROCF, Rey-
Osterrieth complex figure; TMT-A, trail making test part A; SDMT, symbol
digit modalities test; TMT-B, trail making test part B.
*Pearson’s r coefficient significant at P , .05.
**Pearson’s r coefficient significant at P , .01.
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In comparison to scenario 1, applying scenarios 2 and
3 produced a decrease in percentages of multiple domain
A-MCI (from 86% to 77% and 73%, respectively) and
an increase in percentages of single domain NA-MCI
(from 8% to 18% and 20%, respectively). Ninety-five
percent CI for percentages of MCI subtypes in all sce-
narios are shown in Fig. 3 using a forest plot. The
95% CI distribution of percentages of diagnoses made
according to scenarios 1 and 3 for the subtypes A-MCI
multiple domain and NA-MCI single domain were not
overlapping.
Mean MMSE scores and SD for each MCI subgroup are
shown in Fig. 2. In all scenarios, significant differences in
MMSE scores distributions were found across MCI sub-
groups (scenario 1: F 5 5.49, P , .01; scenario 2:
F 5 8.43, P , .01; and scenario 3: F 5 8.04, P , .01).
The mean MMSE scores of A-MCI multiple domain group
always resulted lower compared with the other MCI sub-
types, and post hoc tests (Bonferroni) showed significant
differences between A-MCI multiple domain group and
NA-MCI groups, either single or multiple domain, in all sce-
narios (data not shown).
3.4. Neuroimaging characterization of single and multiple
domain MCI
Of the 153 enrolled patients, 82 (54%) had a severe de-
gree of WMH, 103 (67%) at least one lacunar infarct, 28
(18%) a severe degree of global cortical atrophy, and 94
(61%) a mean MTA score !3.
Using Pearson’s c2 test, only MTA showed a statistically
significant association with multiple domain MCI (68% vs.
38% multiple vs. single domain MCI; c2 5 6.82,
P 5 .009). Global cortical atrophy (20% vs. 10% multiple
vs. single domain), WMH (55% vs. 43%), and lacunar in-
farcts (68% vs. 67%) were not significantly associated
with single or multiple domain MCI.
The 95% CI distribution of percentages of neuroimaging
variables were largely overlapping between scenarios 1 and
3 for all MCI subtypes (data not shown). Comparing neuro-
imaging variables that could characterize those MCI sub-
types whose distributions of diagnoses differed between
the scenarios, the A-MCI multiple domain group resulted al-
ways in high percentages of both lacunar infarcts (66% vs.
69%, scenario 1 vs. 3) and mean MTA score !3 (70% vs.
Fig. 2. Distributions of MCI subtypes according to three possible scenarios. Definitions of scenarios are as follows: Scenario 1: at least one test borderline;
Scenario 2: at least two tests borderline; and Scenario 3: at least one test impaired. Percentages refer to the total number of MCI patients in each scenario. Ab-
breviations: MCI, mild cognitive impairment; A-MCI, amnestic mild cognitive impairment; NA-MCI, nonamnestic mild cognitive impairment; MMSE, mini
mental state examination.
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68%, scenario 1 vs. 3), whereas the NA-MCI single domain
group showed high percentages of lacunar infarcts (73% vs.
73%, scenario 1 vs. 3; Fig. 4).
4. Discussion
This study represents the first attempt to assess the effect
of the operationalization of MCI consensus criteria in terms
of subtypes distribution in a sample of patients with SVD.
We found that the application of differently operationalized
criteria led to minimal changes in the total number of pa-
tients diagnosed as MCI but to more marked differences in
the frequency of MCI subtypes. Most of our patients were
classified as multiple-domain A-MCI in line with the Win-
blad et al.’s hypothesis. However, about one-fifth showed a
single-domain profile. Finally, in comparison with single-
domain MCI patients, multiple-domain patients showed
higher frequency of severe MTA.
Multiple-domainMCI was highly prevalent in our sample
across all scenarios and this is in line with the hypothesis that
MCI subtypes characterized by impairment in nonmemory
domains, such as executive function and visuospatial skills,
may have a vascular etiology [5,34–36].
The fact that when using more restrictive criteria to
diagnose MCI, a certain number of our patients were
diagnosed with single NA domain MCI supports the
hypothesis that MCI patients with SVD might have spe-
cific patterns of cognitive impairments in domains other
than memory [34,35]. This would expand the clinical
spectrum of vascular MCI.
Recent studies have examined empirically derived sub-
types of MCI based on patterns of neuropsychological defi-
cits in clinic- and community-based samples and most of
them had identified homogenous subgroups that were
consistent across studies and could reflect a common etiol-
ogy (e.g., memory impaired group, multidomain amnestic
group, and dysexecutive group) [1,34,36]. In particular,
Delano-Wood et al. [34] found significantly greater levels
of white matter changes burden on neuroimaging in their
empirically derived dysexecutive MCI subgroup, consis-
tently with the hypothesis of the association of cerebrovas-
cular lesions with this pattern of deficits.
Fig. 3. Ninety-five percent confidence intervals of percentage distributions ofMCI subtypes in three scenarios. Abbreviations:MCI, mild cognitive impairment;
A-MCI, amnestic mild cognitive impairment; NA-MCI, nonamnestic mild cognitive impairment.
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Most of our patients fell in the A-MCI group across
different scenarios. This is likely a result of the fact that
in Winblad et al.’s criteria for MCI memory deficits are
hierarchically prevailing over other cognitive domains in
the diagnostic algorithm. As a result, patients with mild
memory deficits and severe deficits in other domains are
nonetheless classified as amnestic. Taking into account
the mentioned aspect and applying the three different sce-
narios, we had to decide how to classify those patients
with borderline performances in memory domain and
frankly abnormal performances in other cognitive do-
mains. We decided to classify as A-MCI only those pa-
tients who had at least one memory score borderline
and no frankly impaired scores in other cognitive do-
mains; otherwise patients were assigned to NA-MCI.
For MCI subtyping, it seems advisable to take into ac-
count the overall neuropsychological profile of patients
without attributing to memory a prominent role. This is
in line with the recent proposal of redefinition of VMCI
diagnostic criteria which, according to a comprehensive
and neuropsychological approach, excludes the prevailing
position of memory impairment and gives equal impor-
tance to other cognitive domains [11].
Previous reports are conflicting on the nature and extent
of brain changes associated with MCI subtypes [37].
According to Winblad et al.’s criteria, VMCI should be
characterized by a multidomain profile [5]. However, be-
tween one-sixth and one-fourth of our patients were
Fig. 4. Ninety-five percent confidence intervals of percentage distributions of neuroimaging variables in A-MCI multiple domain and NA-MCI single domain
subtypes between scenarios 1 and 3. Abbreviations: WMH, white matter hyperintensities; A-MCI, amnestic mild cognitive impairment; NA-MCI, nonamnestic
mild cognitive impairment; GCA, global cortical atrophy; MTA, medial temporal lobe atrophy.
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classified as single domain. To test whether this latter
group differed in neuroimaging terms from the multido-
main group, for example for an overrepresentation of
degenerative aspects, we compared MRI findings and
found that instead neurodegenerative features, such as
MTA, were more prevalent in the multidomain group,
particularly in the A-MCI multi domain. On the other
hand, the main neuroimaging characteristics emerged in
the NA-MCI single domain group was the presence of
lacunar infarcts.
Limitations of our study need to be considered. The main
limitation is that each cognitive domain included a different
number of tests and scores. Theoretically, having more
cognitive scores increases the likelihood of finding a deficit
in that specific domain. The memory impairment was eval-
uated taking into account four cognitive scores, whereas
the attention/executive impairment was based on five scores
and this difference is likely to influence the decrease in pro-
portion of A-MCI, and the resulting increase of NA-MCI,
when using more restrictive criteria. Distribution of cogni-
tive performances confirmed that attention-executive
dysfunction was one of the prominent features, but impair-
ments in memory and high-level visuoconstructional abili-
ties were also observed in our sample despite the lower
number of available scores.
Another consequence of different number of tests and
scores is that language and constructional praxis impair-
ments might have been underestimated in comparison with
memory and attention/executive functions deficits. To verify
the impact of different number of tests and scores in each
cognitive domain on MCI subtypes distributions, we
explored also an operationalization based on three cognitive
domains: memory and executive functions (as described
mentioned), and a third “mixed” cognitive domain that
pooled the two language tests and the constructional praxis
test. Applying this three-domain strategy, distributions of
MCI subtypes according to three possible scenarios were
basically the same of our original analysis. In all scenarios,
only one patient, classified as NA-MCI multiple domain in
the four-domain analysis, moved to the NA-MCI single
domain group in the three-domain analysis. Also, 95% CI
for percentages of MCI subtypes in all scenarios remained
the same. Furthermore, our results showed a good internal
consistency of cognitive domains in the four-domain
approach. We therefore decided to use the model confirmed
also in the previous methodological article on the psycho-
metric properties of the VMCI-Tuscany neuropsychological
battery [14].
A second limitation is the use of the number of impaired
cognitive scores, as opposed to that of an overall summary
score, for the determination of cognitive impairment. A
recent study found that summary scores, such as averaging
of z-scores and item response theory score, provided a
more accurate determination of the prevalence of cognitive
impairment in a very large sample of 461 patients and 724
controls [38]. Although the use of the number of impaired
cognitive scores has been demonstrated to be less sensitive
than summary scores, the relatively small sample in our
study did not allow the use of such sophisticated methods;
that, however, will have to be implemented in further studies
on the optimization of operationalization of criterion of mild
cognitive impairment.
A third limitation is that the multiple-domain MCI group
was notably larger than the single-domain MCI group and
this reduced the statistical power of comparative analyses.
Another possible limitation may be the lack of cerebro-
spinal fluid biomarkers and positron emission tomography
assessments of markers of Alzheimer disease to better
define the etiology of our sample. This, however, reflects
the current situation in most centers. On the other hand,
the lack of an association between cerebrovascular burden
and MCI subtypes may be due also to the quantification of
WMH according to a visual rating scale, rather than a
more objective and metric methodology. Therefore, we
cannot be completely sure that our sample was composed
of patients with pure vascular MCI. Yet, this patient sam-
ple likely represents what is encountered in clinical prac-
tice. At the end of the ongoing follow-up, data will be
available concerning the incidence of dementia and its
subtypes and their possible association with baseline neu-
ropsychological patterns of deficits. Finally, it is impor-
tant to note that our results and conclusions refer to a
sample of patients with MCI and SVD and not to the
global MCI population.
Cognitive profiling of MCI subtypes is important from
the clinical, research, and epidemiologic points of view. In
this sense, the hierarchical approach used in the Winblad
et al.’s criteria, based on the presence or absence of memory
deficits, could not be optimal to identify other specific pat-
terns of cognitive impairment, particularly in patients with
cerebrovascular diseases thought to have domains other
than memory mainly affected. A more comprehensive eval-
uation of the cognitive profile, based on several hierarchical-
ly equivalent cognitive domains, should guide the
classification, and future studies in this regard are warranted.
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RESEARCH IN CONTEXT
1. Systematic review: The authors reviewed the litera-
ture using standard databases (e.g., PubMed). The
topic is in expansion, and relevant articles related
to the debate on best criteria for MCI diagnosis and
their operationalization are appropriately cited.
2. Interpretation: Our findings suggest that the hierar-
chical approach used in current MCI criteria could
not be optimal to identify specific patterns of cogni-
tive impairment in patients with cerebrovascular dis-
eases who have domains other than memory mainly
affected.
3. Future directions: Our study provides a framework
for further studies on operationalization of criteria
for MCI in patients with cerebrovascular disease:
(1) studies on MCI diagnostic criteria based on a
comprehensive cognitive evaluation without a hierar-
chical approach; (2) studies on comparisons between
clinically and empirically derived subtypes of MCI
based on patterns of neuropsychological deficits;
and (3) studies on the reliability of different MCI
diagnostic approaches on the progression to demen-
tia and its subtypes.
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Alberto Chiti, Mirco Cosottini, Giovanni Orlandi, Cristina
Pagni, Gabriele Siciliano, and Gloria Tognoni.
University of Siena: Antonio Federico, Nicola De
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Formichi, Claudia Gambetti, Antonio Giorgio, Francesca
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